Executives On The Move: Change At The Top For BMS Among other New CEOs
Recent executive moves in the industry include new CEOs at Viridian Therapeutic, Opthea and Gyre Therapeutics, while Bristol Myers Squibb confirms its new leadership.
You may also be interested in...
In accepting Scrip’s Lifetime Achievement Award, Ovid Therapeutics’ CEO called on pharma to show responsible leadership and live up to its potential to do good for society.
Recent moves in the industry include internal rejigs at Homology Medicines, Virpax Pharmaceuticals, CytoDyn and Applied Therapeutics, plus new board members at Neuroscientific Biopharmaceuticals.
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.